FDAnews
www.fdanews.com/articles/175343-optovues-angiovue-imaging-system-blessed-with-fda-clearance
Green_Light.gif

Optovue’s AngioVue Imaging System Blessed With FDA Clearance

February 12, 2016

The FDA has cleared the Optovue AngioVue imaging system, which provides physicians with a noninvasive, dyeless technique to quickly visualize the presence or absence of flow in the blood vessels of the retina.

“Since we first introduced this technology to markets outside the U.S. 14 months ago, the technology is in daily clinical use at [more than] 525 clinical sites where it provides a more patient-friendly approach to diseases of the retina that lead to progressive blindness,” said Jay Wei, founder and chief executive officer at Optovue.

The company says it is the first to develop and commercialize this type of optical coherence tomography angiography technology. — Jonathon Shacat